Morbidity and mortality of sickle cell disease patients is unaffected by splenectomy: evidence from three decades of follow-up in a high-income setting

Affiliations

• ¹ Center for Microcythemia, Congenital Anemia and Iron Dysmetabolism, Galliera Hospital, Genoa.
• ² ForAnemia Foundation, Genoa.
• ³ Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London.
• ⁴ Reference Centre for Hemoglobinopathies, AOU San Luigi Gonzaga Hospital, Orbassano.
• ⁵ Campus of Haematology Franco and Piera Cutino, AOOR Villa Sofia-V. Cervello, Palermo.
• ⁶ Thalassemia Unit, P.O. Vittorio Emanuele III, Gela, Caltanissetta Italy.
• ⁷ Thalassemia Center, P.O. Giovanni Paolo II, Ragusa.
• ⁸ Department of Medicine and Medical Specialities, IRCCS Ca' Granda Foundation, Maggiore Policlinico Hospital, Milan.
• ⁹ Department of Medicine, University of Verona and AOUI Verona, Policlinico GB Rossi, Verona.
• ¹⁰ Department of Clinical and Biological Sciences, University of Turin.
• ¹¹ Center for Microcythemia, Congenital Anemia and Iron Dysmetabolism, Galliera Hospital, Genoa. gianluca.forni@galliera.it.